UICC Opens the World Cancer Leaders’ Summit 2025

World Cancer Leaders UICC

“Delivering Innovation with Integrity” - ACT 4 Children Initiative at the 2025 WCLS

ACT 4 Children

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

2025 Selected Abstracts for the European Cancer Summit - European Cancer Organisation

European Cancer Organisation European Cancer Summit

FDA Approves Ziftomenib (Komzifti) for Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

ziftomenib

The World’s First Trial of a Vaccine to Prevent Lung Cancer - Cancer Research UK

Cancer Research UK

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

Pediatric Cardio-Oncology Consortium to Host Virtual Summit on December 4, 2025

Cardio-Oncology-Consortium

OncoCalendar

« All Events

  • This event has passed.

ESMO Targeted Anticancer Therapies Asia Congress 2025

Jul 18 • 12:00 AM - Jul 20 • 12:00 AM
ESMO Targeted Anticancer Therapies Asia Congress 2025

The ESMO TAT Asia Congress 2025 will be held in Hong Kong SAR, China on July 18-20. This multi-stakeholder forum brings together key players in cancer drug development, providing a platform to share the latest advances in early clinical trials across the region.

The congress, organized by the European Society for Medical Oncology, will feature in-depth discussions on vital topics such as innovation, digital transformation, research methodology, business insights, regulation, and public policy. ESMO TAT Asia aims to drive progress in cancer treatment and research.

Set in the vibrant city of Hong Kong, the congress promises to be a dynamic gathering of industry leaders, academics, clinicians, and regulators, fostering international cooperation and accelerating anticancer research.

Don’t miss this opportunity to be part of the conversation and stay tuned for registration details.

Find more information about ESMO at OncoDaily.com.

Details

Organizer